Net Cash Provided by (Used in) Investing Activities of Mosaic ImmunoEngineering Inc. from 31 Aug 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Mosaic ImmunoEngineering Inc. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Aug 2010 to 31 Dec 2024.
  • Mosaic ImmunoEngineering Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was $0, a 100% decline year-over-year.
  • Mosaic ImmunoEngineering Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $0, a 100% decline from 2023.
  • Mosaic ImmunoEngineering Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $433,000, a 26% increase from 2022.
  • Mosaic ImmunoEngineering Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $343,000, a 1141% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)

Mosaic ImmunoEngineering Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 -$433,000 -100% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $433,000 +$90,000 +26% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $343,000 +$315,363 +1141% 01 Jan 2022 31 Dec 2022 10-K 15 Apr 2024 2023 FY
2021 $27,637 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2019 $750,000 +$1,322,754 01 Jun 2019 31 May 2020 10-K 24 Aug 2020 2020 FY
2018 $572,754 -$2,771,289 -126% 01 Jun 2018 31 May 2019 10-K 24 Aug 2020 2020 FY
2017 $2,198,535 +$1,067,638 +94% 01 Jun 2017 31 May 2018 10-K 29 Aug 2019 2019 FY
2016 $1,130,897 +$1,072,397 +1833% 01 Jun 2016 31 May 2017 10-K 29 Aug 2018 2018 FY
2015 $58,500 01 Jun 2015 31 May 2016 10-K 29 Aug 2017 2017 FY
2013 $1,130,532 -$5,064,089 -129% 01 Jun 2013 31 May 2014 10-K 19 Aug 2014 2014 FY
2012 $3,933,557 +$5,161,706 01 Jun 2012 31 May 2013 10-K 19 Aug 2014 2014 FY
2011 $1,228,149 -$6,926,624 -122% 01 Jun 2011 31 May 2012 10-K 23 Aug 2013 2013 FY
2010 $5,698,475 01 Jun 2010 31 May 2011 10-K 29 Aug 2012 2012 FY

Mosaic ImmunoEngineering Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 -$77,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q1 2023 $77,000 +$77,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $0 -$27,637 -100% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $27,637 +$27,637 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q3 2020 $605,215 +$355,215 +142% 01 Jun 2020 31 Aug 2020 10-Q 15 Oct 2020 2021 Q1
Q2 2020 $0 30 Mar 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q1 2020 $0 30 Mar 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q3 2019 $250,000 +$250,000 01 Jun 2019 31 Aug 2019 10-Q 11 Oct 2019 2020 Q1
Q3 2018 $0 +$500,000 01 Jun 2018 31 Aug 2018 10-Q 11 Oct 2019 2020 Q1
Q3 2017 $500,000 -$747,297 -302% 01 Jun 2017 31 Aug 2017 10-Q 15 Oct 2018 2019 Q1
Q3 2016 $247,297 +$231,297 +1446% 01 Jun 2016 31 Aug 2016 10-Q 16 Oct 2017 2018 Q1
Q3 2015 $16,000 -$184,376 -92% 01 Jun 2015 31 Aug 2015 10-Q 15 Oct 2015 2016 Q1
Q3 2014 $200,376 +$194,126 +3106% 01 Jun 2014 31 Aug 2014 10-Q 15 Oct 2015 2016 Q1
Q3 2013 $6,250 -$295,671 -98% 01 Jun 2013 31 Aug 2013 10-Q 15 Oct 2014 2015 Q1
Q3 2012 $301,921 +$2,776,916 01 Jun 2012 31 Aug 2012 10-Q 15 Oct 2013 2014 Q1
Q3 2011 $2,474,995 -$3,896,365 -274% 01 Jun 2011 31 Aug 2011 10-Q 15 Oct 2012 2013 Q1
Q3 2010 $1,421,370 01 Jun 2010 31 Aug 2010 10-Q 17 Oct 2011 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.